Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
Open accessThe DOI matches its Crossref record; 278 of the 284 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) is one of the most common aggressive carcinoma types worldwide, characterized by unfavorable curative effect and poor prognosis. Epidemiological data re-vealed that CRC risk is increased in patients with metabolic syndrome (MetS) and its serum components (e.g., hyperglycemia). High glycemic index diets, which chronically raise post-prandial blood glucose, may at least in part increase colon cancer risk via the insulin/insulin-like growth factor 1 (IGF-1) signaling pathway. However, the underlying mechanisms linking IGF-1 and MetS are still poorly understood. Hyperactivated glucose uptake and aerobic glycolysis (the Warburg effect) are considered as a one of six hallmarks of cancer, including CRC. However, the role of insulin/IGF-1 signaling during the acquisition of the Warburg metabolic phenotypes by CRC cells is still poorly understood. It most likely results from the interaction of multiple processes, directly or indirectly regulated by IGF-1, such as activation of PI3K/Akt/mTORC, and Raf/MAPK signaling pathways, activation of glucose transporters (e.g., GLUT1), activation of key glycolytic enzymes (e.g., LDHA, LDH5, HK II, and PFKFB3), aberrant expression of the oncogenes (e.g., MYC, and KRAS) and/or overexpression of signaling proteins (e.g., HIF-1, TGF-β1, PI3K, ERK, Akt, and mTOR). This review describes the role of IGF-1 in glucose metabolism in physiology and colorectal carcinogenesis, including the role of the insulin/IGF system in the Warburg effect. Furthermore, current therapeutic strategies aimed at repairing impaired glucose metabolism in CRC are indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic illustration of the insulin/IGF-1 system involved in the development and progression of colorectal cancer (CRC) through direct (mitotic effects) and indirect (aerobic glycolysis) activity. [↑,↓-increase (up-regulation)/decrease (down-regulation) expression/level; AMPK-adenosine monophosphate (AMP)-activated protein kinase; CRNDE-colorectal neoplasia differentially expressed gene; GLUT-glucose transporter; GH-R-growth hormone receptor; GRP78-glucose-regulated protein 78; HIF-1α, -β-hypoxia-inducible transcription factor-1α, -β; HK II-hexokinase II; IGF-1-insulin-like growth factor 1; IGFBP-1;-2-IGF binding proteins 1,-2; JAK/STAT3-Janus kinase/signal transducer and activator of transcription; KLK10-kallikrein-related peptidase; LDHA, -5-lactate dehydrogenase A, -5; mKRAS-mutant KRAS gene; mMYC-mutant MYC gene; mTP53-mutant tumor protein 53 gene; PI3K/Akt/mTOR-phosphatidylinositol 3 kinase/Akt/mammalian target of rapamycin complex; WAT-white adipose tissue].](https://figures.cochat.ai/paper-figures/f88b765def11457a838eb19e9a83d462/insulin-like-growth-factor-1-igf-1-signaling-in-glucose-metabolism-in-colorectal-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IGF1 and IGF2 have substantial effects on cell proliferation and differentiation and are effective inhibitors of apoptosis [174].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [174]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Zaafar, D. K., Zaitone, S. A., & Moustafa, Y. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100562 · Cited by 74
RetractedWu, X., Wang, L., Yang, D., Qu, M., Yang, Y., Guo, F. Y., Han, L., & Xue, J. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26399 · Cited by 51
RetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150 · cited 2×
“Although it is acknowledged that glycolysis occurs in CRC, the mechanism driving it remains largely unknown [33,40,42].”
BackgroundmTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941 · cited 1×
“It is worth noting that mTOR signaling plays an important role in mitochondrial metabolism and is also a major downstream target of the 5′ adenosine monophosphate (AMP)-activated protein kinase (AMPK) signaling [66].”
BackgroundInsulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
DAUGHADAY, W. H., & ROTWEIN, P. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-1-68 · Cited by 1,725
Rinderknecht, E., & Humbel, R. E. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40889-1 · Cited by 1,545
Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man.
Roediger, W. E. (1980) · Gut · doi:10.1136/gut.21.9.793 · Cited by 1,310
The Somatomedin Hypothesis: 2001
Le Roith, D., Bondy, C., Yakar, S., Liu, J.-L., & Butler, A. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.1.0419 · Cited by 1,257
D'Ercole, A. J., Stiles, A. D., & Underwood, L. E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.3.935 · Cited by 1,186
Ma, J., Pollak, M. N., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C. H., & Stampfer, M. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.620 · Cited by 1,119
Glucose transporters in the 21st Century
Thorens, B., & Mueckler, M. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00712.2009 · Cited by 1,013
Insulin‐like growth factors I and II
HUMBEL, R. E. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15595.x · Cited by 999
Donohoe, D. R., Collins, L. B., Wali, A., Bigler, R., Sun, W., & Bultman, S. J. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.033 · Cited by 993
Insulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence
Giovannucci, E. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.11.3109s · Cited by 959
Obesity as a Major Risk Factor for Cancer
De Pergola, G., & Silvestris, F. (2013) · Journal of Obesity · doi:10.1155/2013/291546 · Cited by 959
Buzzai, M., Jones, R. G., Amaravadi, R. K., Lum, J. J., DeBerardinis, R. J., Zhao, F., Viollet, B., & Thompson, C. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4447 · Cited by 923
Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
Eizirik, D. L., Pasquali, L., & Cnop, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0355-7 · Cited by 854
The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth
Khandwala, H. M., McCutcheon, I. E., Flyvbjerg, A., & Friend, K. E. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0399 · Cited by 843
Xu, R.-H., Pelicano, H., Zhou, Y., Carew, J. S., Feng, L., Bhalla, K. N., Keating, M. J., & Huang, P. (2005) · Cancer Research · doi:10.1158/0008-5472.613.65.2 · Cited by 835
Revisiting the Warburg effect: historical dogma versus current understanding
Vaupel, P., & Multhoff, G. (2021) · The Journal of Physiology · doi:10.1113/jp278810 · Cited by 830
Fukuda, R., Hirota, K., Fan, F., Jung, Y. D., Ellis, L. M., & Semenza, G. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203781200 · Cited by 821
Obesity and diabetes: the increased risk of cancer and cancer-related mortality
Gallagher, E. J., & LeRoith, D. (2015) · Physiological Reviews · doi:10.1152/physrev.00030.2014 · Cited by 806
Kaaks, R. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.19.1592 · Cited by 653
The IGF‐1 receptor in cancer biology
Baserga, R., Peruzzi, F., & Reiss, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11487 · Cited by 642
Juul, A., Scheike, T., Davidsen, M., Gyllenborg, J., & Jørgensen, T. (2002) · Circulation · doi:10.1161/01.cir.0000027563.44593.cc · Cited by 640
Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy Adults
Guler, H.-P., Zapf, J., & Froesch, E. R. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707163170303 · Cited by 554
IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?
Allard, J. B., & Duan, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00117 · Cited by 515
Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
Grimberg, A., & Cohen, P. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<1::aid-jcp1>3.0.co;2-j · Cited by 506
Increased Blood Glucose and Insulin, Body Size, and Incident Colorectal Cancer
Schoen, R. E., Tangen, C. M., Kuller, L. H., Burke, G. L., Cushman, M., Tracy, R. P., Dobs, A., & Savage, P. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.13.1147 · Cited by 500
Sandhu, M. S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.13.972 · Cited by 496
Duan, C., Ren, H., & Gao, S. (2010) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2010.04.009 · Cited by 492
Obesity and cancer risk: the role of the insulin-IGF axis
Renehan, A. G., Frystyk, J., & Flyvbjerg, A. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.08.006 · Cited by 480
Donohoe, D. R., Holley, D., Collins, L. B., Montgomery, S. A., Whitmore, A. C., Hillhouse, A., Curry, K. P., Renner, S. W., Greenwalt, A., Ryan, E. P., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0501 · Cited by 474
Sandhu, M. S., Heald, A. H., Gibson, J. M., Cruickshank, J. K., Dunger, D. B., & Wareham, N. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08655-5 · Cited by 470
Serum levels of insulin-like growth factor I and its binding proteins in health and disease
Juul, A. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00038-8 · Cited by 467
2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy
Zhang, D., Li, J., Wang, F., Hu, J., Wang, S., & Sun, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.003 · Cited by 462
Signalling by insulin and IGF receptors: supporting acts and new players
Siddle, K. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0022 · Cited by 456
Dietary components that regulate serum somatomedin-C concentrations in humans.
Isley, W. L., Underwood, L. E., & Clemmons, D. R. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110757 · Cited by 433
The Warburg Effect and the Hallmarks of Cancer
Schwartz, L., Supuran, C., & Alfarouk, K. (2017) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520616666161031143301 · Cited by 426
Giovannucci, E. L., Pollak, M., Platz, E. A., Willett, W. C., Stampfer, M. J., Majeed, N., Colditz, G. A., Speizer, F. E., & Hankinson, S. E. (2000) · PubMed · Cited by 401
Colao, A., Grasso, L. F. S., Giustina, A., Melmed, S., Chanson, P., Pereira, A. M., & Pivonello, R. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0071-6 · Cited by 396
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
Wu, Y., Yakar, S., Zhao, L., Hennighausen, L. G., & LeRoith, D. (2002) · PubMed · Cited by 380
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Gadelha, M. R., Kasuki, L., Lim, D. S. T., & Fleseriu, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00115 · Cited by 363
Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC
Satoh, K., Yachida, S., Sugimoto, M., Oshima, M., Nakagawa, T., Akamoto, S., Tabata, S., Saitoh, K., Kato, K., Sato, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710366114 · Cited by 361
Free insulin-like growth factors in human obesity
Frystyk, J., Vestbo, E., Skjærbaek, C., Mogensen, C. E., & Ørskov, H. (1995) · Metabolism · doi:10.1016/0026-0495(95)90219-8 · Cited by 353
Metabolic Pathways Regulating Colorectal Cancer Initiation and Progression
La Vecchia, S., & Sebastián, C. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.018 · Cited by 349 · cited 2×
“Primary cellular metabolism undergoes significant rearrangements during the initiation, growth and progression (including metastasis spread) of CRC (reviewed in: [35]).”
BackgroundMechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1
LeRoith, D., & Yakar, S. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0427 · Cited by 344 · cited 2×
“IGF-1 also has opposite effects on carbohydrate, lipid and protein metabolism compared to GH [52,101,102].”
BackgroundLiver-Specific igf-1 Gene Deletion Leads to Muscle Insulin Insensitivity
Yakar, S., Liu, J.-L., Fernandez, A. M., Wu, Y., Schally, A. V., Frystyk, J., Chernausek, S. D., Mejia, W., & Le Roith, D. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1110 · Cited by 343
Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies
Pisani, P. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801954451 · Cited by 329
Guler, H. P., Schmid, C., Zapf, J., & Froesch, E. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2868 · Cited by 322
Insulin/IGF-1 Drives PERIOD Synthesis to Entrain Circadian Rhythms with Feeding Time
Crosby, P., Hamnett, R., Putker, M., Hoyle, N. P., Reed, M., Karam, C. J., Maywood, E. S., Stangherlin, A., Chesham, J. E., Hayter, E. A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.02.017 · Cited by 309
Metabolic Actions of Insulin-Like Growth Factor-I in Normal Physiology and Diabetes
Clemmons, D. R. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.017 · Cited by 297
Insulin-like growth factor-1 deficiency and metabolic syndrome
Aguirre, G. A., De Ita, J. R., de la Garza, R. G., & Castilla-Cortazar, I. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-015-0762-z · Cited by 295
Moses, A. C., Young, S. C., Morrow, L. A., O'Brien, M., & Clemmons, D. R. (1996) · Diabetes · doi:10.2337/diab.45.1.91 · Cited by 291 · cited 2×
“It has been confirmed that IGF-1 is necessary for insulin sensitivity in physiology [54], in DM I [64,105], as well as in DM II [106].”
BackgroundReduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes
Zhang, Z.-J., Zheng, Z.-J., Kan, H., Song, Y., Cui, W., Zhao, G., & Kip, K. E. (2011) · Diabetes Care · doi:10.2337/dc11-0512 · Cited by 291
Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
Soranna, D., Scotti, L., Zambon, A., Bosetti, C., Grassi, G., Catapano, A., La Vecchia, C., Mancia, G., & Corrao, G. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0462 · Cited by 274
Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer
Bultman, S. J. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500902 · Cited by 265
Insulin: The Friend and the Foe in the Development of Type 2 Diabetes Mellitus
Rachdaoui, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051770 · Cited by 265
Two insulin-like growth factor I messenger RNAs are expressed in human liver.
Rotwein, P. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.1.77 · Cited by 258
Hepatokines and metabolism: Deciphering communication from the liver
Jensen-Cody, S. O., & Potthoff, M. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101138 · Cited by 252 · cited 3×
“Mechanisms of obesity formation and IR development [2], and the prevalence of metabolic syndrome (MetS), are not yet clear [12,13].”
Background40 YEARS OF IGF1: IGF-binding proteins
Bach, L. A. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0254 · Cited by 252
Rinaldi, S., Cleveland, R., Norat, T., Biessy, C., Rohrmann, S., Linseisen, J., Boeing, H., Pischon, T., Panico, S., Agnoli, C., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.24927 · Cited by 244
The Warburg effect: Insights from the past decade
Upadhyay, M., Samal, J., Kandpal, M., Singh, O. V., & Vivekanandan, P. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.11.003 · Cited by 243
Wolpin, B. M., Meyerhardt, J. A., Chan, A. T., Ng, K., Chan, J. A., Wu, K., Pollak, M. N., Giovannucci, E. L., & Fuchs, C. S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9945 · Cited by 231
Gunter, M. J., Hoover, D. R., Yu, H., Wassertheil-Smoller, S., Rohan, T. E., Manson, J. E., Howard, B. V., Wylie-Rosett, J., Anderson, G. L., Ho, G. Y. F., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2946 · Cited by 229
Koukourakis, M. I., Giatromanolaki, A., Simopoulos, C., Polychronidis, A., & Sivridis, E. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-2343-7 · Cited by 227
Collett-Solberg, P. F., & Cohen, P. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70342-x · Cited by 225
Jiang, Y., Ben, Q., Shen, H., Lu, W., Zhang, Y., & Zhu, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9617-y · Cited by 221
Ellis, B. C., Graham, L. D., & Molloy, P. L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.10.016 · Cited by 210
The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity
Clemmons, D. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420660 · Cited by 203
Esposito, K., Chiodini, P., Capuano, A., Bellastella, G., Maiorino, M. I., Rafaniello, C., Panagiotakos, D. B., & Giugliano, D. (2013) · Endocrine · doi:10.1007/s12020-013-9939-5 · Cited by 197
The role of growth hormone and insulin-like growth factor-I in the liver
Takahashi, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071447 · Cited by 193
Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects
Kamarudin, M. N. A., Sarker, M. M. R., Zhou, J.-R., & Parhar, I. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1495-2 · Cited by 191
The role of the growth hormone–insulin‐like growth factor axis in glucose homeostasis
Holt, R. I. G., Simpson, H. L., & Sönksen, P. H. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00827.x · Cited by 191
Diabetes Mellitus and Colorectal Cancer Prognosis: A Meta-analysis
Mills, K. T., Bellows, C. F., Hoffman, A. E., Kelly, T. N., & Gagliardi, G. (2013) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e3182a479f9 · Cited by 188
Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment
Suh, S., & Kim, K.-W. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0177 · Cited by 185
Maione, L., Brue, T., Beckers, A., Delemer, B., Petrossians, P., Borson-Chazot, F., Chabre, O., François, P., Bertherat, J., Cortet-Rudelli, C., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-1064 · Cited by 185
Sesti, G., Sciacqua, A., Cardellini, M., Marini, M. A., Maio, R., Vatrano, M., Succurro, E., Lauro, R., Federici, M., & Perticone, F. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.120 · Cited by 184
Butyrate and Colorectal Cancer: The Role of Butyrate Transport
Gonçalves, P., & Martel, F. (2013) · Current Drug Metabolism · doi:10.2174/1389200211314090006 · Cited by 179
Weinstein, D., Simon, M., Yehezkel, E., Laron, Z., & Werner, H. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.912 · Cited by 179
Multi-Target Approaches in Metabolic Syndrome
Lillich, F. F., Imig, J. D., & Proschak, E. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.554961 · Cited by 178
Characterization of insulinlike growth factor I receptors in human colon cancer
Guo, Y., Narayan, S., Yallampalli, C., & Singh, P. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)70001-r · Cited by 177
Role of IGF-I signaling in muscle bone interactions
Bikle, D. D., Tahimic, C., Chang, W., Wang, Y., Philippou, A., & Barton, E. R. (2015) · Bone · doi:10.1016/j.bone.2015.04.036 · Cited by 176
Challenges in the diagnosis and management of acromegaly: a focus on comorbidities
Abreu-Lomba, A., Tovar, A. P., Castellanos, R., Valenzuela, Á., Giraldo, C. M. G., Castellanos-Pinedo, A., Pantoja, D., Barrera, C. A. B., Franco, H. I., Ribeiro‐Oliveira, A., et al. (2016) · Pituitary · doi:10.1007/s11102-016-0725-2 · Cited by 176
Peeters, P. J. H. L., Bazelier, M. T., Leufkens, H. G. M., de Vries, F., & De Bruin, M. L. (2015) · Diabetes Care · doi:10.2337/dc14-1175 · Cited by 173
miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect
SUN, Y., ZHAO, X., ZHOU, Y., & HU, Y. (2012) · Oncology Reports · doi:10.3892/or.2012.1958 · Cited by 169
Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis
Rokkas, T., Pistiolas, D., Sechopoulos, P., Margantinis, G., & Koukoulis, G. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3484 · Cited by 167
Taniguchi, K., Sugito, N., Kumazaki, M., Shinohara, H., Yamada, N., Nakagawa, Y., Ito, Y., Otsuki, Y., Uno, B., Uchiyama, K., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.026 · Cited by 163
Starvation, Stress Resistance, and Cancer
Buono, R., & Longo, V. D. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.01.008 · Cited by 162
Varma Shrivastav, S., Bhardwaj, A., Pathak, K. A., & Shrivastav, A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00286 · Cited by 157
Bach, M. A., Shen‐Orr, Z., Lowe, W. L., Roberts, C. T., & LeRoith, D. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90054-2 · Cited by 155
Involvement of insulin-like growth factor-I in the control of glucose homeostasis
Clemmons, D. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.006 · Cited by 154
Multiple Effects of Growth Hormone in the Body: Is it Really the Hormone for Growth?
Devesa, J., Almengló, C., & Devesa, P. (2016) · Clinical Medicine Insights: Endocrinology and Diabetes · doi:10.4137/cmed.s38201 · Cited by 153
Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon
Freier, S., Weiss, O., Eran, M., Flyvbjerg, A., Dahan, R., Nephesh, I., Safra, T., Shiloni, E., & Raz, I. (1999) · Gut · doi:10.1136/gut.44.5.704 · Cited by 150
Insulin-Like Growth Factor I and the Development of Colorectal Neoplasia in Acromegaly
Jenkins, P. J., Frajese, V., Jones, A.-M., Camacho-Hübner, C., Lowe, D. G., Fairclough, P. D., Chew, S. L., Grossman, A. B., Monson, J., & BESSER, G. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6806 · Cited by 150
Wang, J., Wang, H., Liu, A., Fang, C., Hao, J., & Wang, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.3318 · Cited by 149
Colorectal Cancer and Metabolism
Brown, R. E., Short, S. P., & Williams, C. S. (2018) · Current Colorectal Cancer Reports · doi:10.1007/s11888-018-0420-y · Cited by 145
Differential Effects of Alternate-Day Fasting Versus Daily Calorie Restriction on Insulin Resistance
Gabel, K., Kroeger, C. M., Trepanowski, J. F., Hoddy, K. K., Cienfuegos, S., Kalam, F., & Varady, K. A. (2019) · Obesity · doi:10.1002/oby.22564 · Cited by 144
Murphy, N., Carreras-Torres, R., Song, M., Chan, A. T., Martin, R. M., Papadimitriou, N., Dimou, N., Tsilidis, K. K., Banbury, B., Bradbury, K. E., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.020 · Cited by 142
Pell, J. M., SAUNDERS, J. C., & Gilmour, R. S. (1993) · Endocrinology · doi:10.1210/endo.132.4.8462477 · Cited by 141
Effect of exercise on colorectal cancer prevention and treatment
Oruç, Z., & Ma, K. (2019) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v11.i5.348 · Cited by 141
Liver-Derived IGF-I is of Importance for Normal Carbohydrate and Lipid Metabolism
Sjögren, K., Wallenius, K., Liu, J.-L., Bohlooly-Y, M., Pacini, G., Svensson, L., Törnell, J., Isaksson, O. G. P., Ahrén, B., Jansson, J.-O., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1539 · Cited by 136
Diabetes and cancer: Associations, mechanisms, and implications for medical practice
Xu, C.-X. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i3.372 · Cited by 135
Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.
Zenobi, P. D., Graf, S., Ursprung, H., & Froesch, E. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115796 · Cited by 135
Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Gatter, K. C., Trarbach, T., Folprecht, G., Shi, M. M., Lebwohl, D., Jalava, T., Laurent, D., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2918 · Cited by 133
Zhao, A. Z., Zhao, H., Teague, J., Fujimoto, W., & Beavo, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3223 · Cited by 133
Saunier, E. F., Antonio, S., Regazzetti, A., Auzeil, N., Laprévôte, O., Shay, J. W., Coumoul, X., Barouki, R., Benelli, C., Laurence Therese, H. U. C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07006-0 · Cited by 133
Role of Insulin-Like Growth Factor Iin Maintaining Normal Glucose Homeostasis
Clemmons, D. R. (2004) · Hormone Research in Paediatrics · doi:10.1159/000080763 · Cited by 130
Insulin-like growth factor (IGF) axis in cancerogenesis
Kasprzak, A., Kwasniewski, W., Adamek, A., & Gozdzicka-Jozefiak, A. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.08.007 · Cited by 130
Self-citationThe ABCs of IGF-I isoforms: impact on muscle hypertrophy and implications for repair
Barton, E. R. (2006) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h06-054 · Cited by 126
Kooijman, R. (1992) · Endocrinology · doi:10.1210/en.131.5.2244 · Cited by 126
Yan, J., & Charles, J. F. (2018) · Calcified Tissue International · doi:10.1007/s00223-018-0395-3 · Cited by 123
Yao, C., Su, L., Shan, J., Zhu, C., Liu, L., Liu, C., Xu, Y., Yang, Z., Bian, X., Shao, J., et al. (2016) · Stem Cells · doi:10.1002/stem.2320 · Cited by 123
Mapping the growth hormone–Stat5b–IGF-I transcriptional circuit
Rotwein, P. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.01.001 · Cited by 123
Yamada, K. (1998) · International Journal of Epidemiology · doi:10.1093/ije/27.5.794 · Cited by 122
Xu, W., Zhang, Z., Zou, K., Cheng, Y., Yang, M., Chen, H., Wang, H., Zhao, J., Chen, P., He, L., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.60 · Cited by 121
(2003) · Hormone and Metabolic Research · doi:10.1055/s-2004-814150 · Cited by 119
Lahm, H., Suardet, L., Laurent, P., Fischer, Jr., Ceyhan, A., Givel, J.-C., & Odartchenko, N. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.69 · Cited by 118
Yao, Z., Xie, F., Li, M., Liang, Z., Xu, W., Yang, J., Liu, C., Li, H., Zhou, H., & Qu, L. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.35 · Cited by 116
Jiménez, B., Mirnezami, R., Kinross, J., Cloarec, O., Keun, H. C., Holmes, E., Goldin, R. D., Ziprin, P., Darzi, A., & Nicholson, J. K. (2013) · Journal of Proteome Research · doi:10.1021/pr3010106 · Cited by 114
Chung, Y. W., Han, D. S., Park, Y. K., Son, B. K., Paik, C. H., Lee, H. L., Jeon, Y., & Sohn, J. H. (2006) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.05.014 · Cited by 112
miR‐181a mediates metabolic shift in colon cancer cells via the PTEN/AKT pathway
Wei, Z., Cui, L., Mei, Z., Liu, M., & Zhang, D. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.037 · Cited by 112
Diabetes in Patients With Acromegaly
Hannon, A. M., Thompson, C. J., & Sherlock, M. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0838-7 · Cited by 111
Jiang, H., Wang, Y., Ai, M.-L., Wang, H., Duan, Z., Wang, H., Zhao, L., Yu, J., Ding, Y., & Wang, S. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.258 · Cited by 110
Peters, G., Gongoll, S., Langner, C., Mengel, M., Piso, P., Klempnauer, J. L., Rüschoff, J., Kreipe, H. H., & von Wasielewski, R. (2003) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-003-0856-5 · Cited by 106
Watkins, L. F., Lewis, L. R., & Levine, A. E. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450227 · Cited by 106
Insulin, Glucose, Insulin Resistance, and Incident Colorectal Cancer in Male Smokers
Limburg, P. J., Stolzenberg‐Solomon, R. Z., Vierkant, R. A., Roberts, K., Sellers, T. A., Taylor, P. R., Virtamo, J. R. K., Cerhan, J. R., & Albanes, D. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.014 · Cited by 104
Association between markers of glucose metabolism and risk of colorectal cancer
Xu, J., Ye, Y., Wu, H., Duerksen-Hughes, P., Zhang, H., Li, P., Huang, J., Yang, J., Wu, Y., & Xia, D. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011430 · Cited by 102
Could ketogenic diet “starve” cancer? Emerging evidence
Barrea, L., Caprio, M., Tuccinardi, D., Moriconi, E., Di Renzo, L., Muscogiuri, G., Colao, A., Savastano, S., & on behalf of the Obesity Programs of nutrition, E. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1847030 · Cited by 102
Growth hormone axis overview - somatomedin hypothesis
Daughaday, W. H. (2000) · Pediatric Nephrology · doi:10.1007/s004670000334 · Cited by 98
Shen, D.-W., Goldenberg, S., Pastan, I., & Gottesman, M. M. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<108::aid-jcp13>3.0.co;2-4 · Cited by 96
Knuppel, A., Fensom, G. K., Watts, E. L., Gunter, M. J., Murphy, N., Papier, K., Perez-Cornago, A., Schmidt, J. A., Smith Byrne, K., Travis, R. C., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1281 · Cited by 96
PTEN, Insulin Resistance and Cancer
Li, A., Qiu, M., Zhou, H., Wang, T., & Guo, W. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170704124611 · Cited by 94
Simpson, H. L., Jackson, N. C., Shojaee-Moradie, F., Jones, R. H., Russell-Jones, D. L., Sönksen, P. H., Dunger, D. B., & Umpleby, A. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031274 · Cited by 94
Insulin-like growth factor-I (IGF-I) and clinical nutrition
Livingstone, C. (2013) · Clinical Science · doi:10.1042/cs20120663 · Cited by 94
Wu, H., Cui, M., Li, C., Li, H., Dai, Y., Cui, K., & Li, Z. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07640 · Cited by 94
Laager, R., Ninnis, R., & Keller, U. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116783 · Cited by 91
Rahmani, J., Kord Varkaneh, H., Clark, C., Zand, H., Bawadi, H., Ryan, P. M., Fatahi, S., & Zhang, Y. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100910 · Cited by 88
Succurro, E., Andreozzi, F., Marini, M. A., Lauro, R., Hribal, M. L., Perticone, F., & Sesti, G. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.12.011 · Cited by 85 · cited 3×
“conducted on more than 100 nondiabetic subjects with a wide range of BMI values showed, progressive reductions in IGF-1 concentrations may be involved in obesity-related changes in both insulin sensitivity and secretion [15].”
BackgroundThe Regulation of IGF-1 Gene Transcription and Splicing during Development and Aging
Oberbauer, A. M. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00039 · Cited by 85
PTBP1-associated microRNA-1 and -133b suppress the Warburg effect in colorectal tumors
Taniguchi, K., 酒井美来, Sugito, N., Kumazaki, M., Shinohara, H., Yamada, N. O., Nakayama, T., Ueda, H., Nakagawa, Y., Ito, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8005 · Cited by 85
Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer
Aguilera, O., Muñoz-Sagastibelza, M., Torrejón, B., Borrero-Palacios, A., del Puerto-Nevado, L., Martínez-Useros, J., Rodriguez-Remirez, M., Zazo, S., García, E., Fraga, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10087 · Cited by 84
Li, Y., Wang, Y., Liu, Z., Guo, X., Miao, Z., & Ma, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00273 · Cited by 84
D’Addio, F., La Rosa, S., Maestroni, A., Jung, P., Orsenigo, E., Ben Nasr, M., Tezza, S., Bassi, R., Finzi, G., Marando, A., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.07.010 · Cited by 81
Clauson, P. G., Brismar, K., Hall, K., Linnarsson, R., & Grill, V (1998) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519850186544 · Cited by 81
Kheirandish, M., Mahboobi, H., Yazdanparast, M. S., Kamal, W., & Kamal, M. A. (2018) · Current Drug Metabolism · doi:10.2174/1389200219666180416161846 · Cited by 80
Russell-Jones, D. L., Bates, A. T., Umpleby, A. M., Hennessy, T. R., Bowes, S. B., Hopkins, K. D., JACKSON, N., Kelly, J., Shojaee‐Moradie, F., JONES, R. H., et al. (1995) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1995.tb01721.x · Cited by 80
Warburg effect, lactate dehydrogenase, and radio/chemo-therapy efficacy
Koukourakis, M. I., & Giatromanolaki, A. N. (2018) · International Journal of Radiation Biology · doi:10.1080/09553002.2018.1490041 · Cited by 79
Trefely, S., Khoo, P. S., Krycer, J. R., Chaudhuri, R., Fazakerley, D. J., Parker, B. L., Sultani, G., Lee, J., Stéphan, J.-P., Torres, E., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.658815 · Cited by 79
Barton, E. R., DeMeo, J., & Lei, H. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01308.2009 · Cited by 78
Importance of the Microbiota Inhibitory Mechanism on the Warburg Effect in Colorectal Cancer Cells
Eslami, M., Sadrifar, S., Karbalaei, M., Keikha, M., Kobyliak, N. M., & Yousefi, B. (2019) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-019-00329-3 · Cited by 78
Zuo, S., Wu, L., Wang, Y., & Yuan, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00274 · Cited by 77
Fenton, J. I., & Birmingham, J. M. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20644 · Cited by 76
GLUT-1 overexpression as an unfavorable prognostic biomarker in patients with colorectal cancer
Yang, J. L., Wen, J., Tian, T., Lu, Z., Wang, Y., Wang, Z., Wang, X., & Yang, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.14352 · Cited by 74
Nosho, K., Yamamoto, H., Taniguchi, H., Adachi, Y., Yoshida, Y., Arimura, Y., Endo, T., Hinoda, Y., & Imai, K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0875 · Cited by 72
Chaudhari, A. B., Gupta, R., Patel, S. A., Velingkaar, N., & Kondratov, R. V. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-08-0624 · Cited by 72
MicroRNA-98 Suppress Warburg Effect by Targeting HK2 in Colon Cancer Cells
Zhu, W., Huang, Y., Pan, Q., Xiang, P., Xie, N., & Yu, H. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4418-5 · Cited by 71
Dworakowska, D., Gueorguiev, M., Kelly, P., Monson, J. P., Besser, G. M., Chew, S. L., Akker, S. A., Drake, W. M., Fairclough, P. D., Grossman, A. B., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-1080 · Cited by 70
Shiratsuchi, I., Akagi, Y., Kawahara, A., Kinugasa, T., Romeo, K., Yoshida, T., Ryu, Y., Gotanda, Y., Kage, M., & Shirouzu, K. (2011) · PubMed · Cited by 70
Wang, K., Huang, W., Sang, X., Wu, X., Shan, Q., Tang, D.-X., Xu, X., & Cao, G. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153191 · Cited by 70
Regulation of colonic epithelial butyrate transport: Focus on colorectal cancer
Gonçalves, P., & Martel, F. (2016) · Porto Biomedical Journal · doi:10.1016/j.pbj.2016.04.004 · Cited by 65
STAT1 Inhibits MiR‐181a Expression to Suppress Colorectal Cancer Cell Proliferation Through PTEN/Akt
Zhang, X., Li, X., Tan, F., Yu, N., & Pei, H. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26000 · Cited by 65
Zhang, Y., Liu, X., Yu, M., Xu, M., Xiao, Y., Ma, W., Huang, L., Li, X., & Ye, X. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118413 · Cited by 65
Zhang, W. B., Aleksic, S., Gao, T., Weiss, E. F., Demetriou, E., Verghese, J., Holtzer, R., Barzilai, N., & Milman, S. (2020) · Cells · doi:10.3390/cells9061368 · Cited by 64
The insulin-like growth factor system: IGFs, IGF-binding proteins and IGFBP-proteases
Lelbach, A., Műzes, G., & Fehér, J. (2005) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.92.2005.2.1 · Cited by 63
Fagin, J. A., Roberts, C. T., LeRoith, D., & Brown, A. T. (1989) · Diabetes · doi:10.2337/diab.38.4.428 · Cited by 63
Berberine inhibits proliferation and migration of colorectal cancer cells by downregulation of GRP78
Gong, C., Hu, X., Xu, Y., Yang, J., Zong, L., Wang, C., Zhu, J., Li, Z., & Lu, D. (2020) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000835 · Cited by 62
High blood glucose levels are associated with higher risk of colon cancer in men: a cohort study
Vulcan, A., Manjer, J., & Ohlsson, B. (2017) · BMC Cancer · doi:10.1186/s12885-017-3874-4 · Cited by 61
Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma
Gao, Y., Katki, H., Graubard, B., Pollak, M., Martin, M., Tao, Y., Schoen, R. E., Church, T., Hayes, R. B., Greene, M. H., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26438 · Cited by 59
Michell, N. P., LANGMAN, M. J. S., & Eggo, M. C. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.337 · Cited by 59
Mao, L., Chen, Q., Gong, K., Xu, X., Xie, Y., Zhang, W., Cao, H., Hu, T., Hong, X., & Zhan, Y. (2018) · Oncology Reports · doi:10.3892/or.2018.6318 · Cited by 59
Wu, M., Li, H., Liu, R., Gao, X., Zhang, M., Liu, P., Fu, Z., Yang, J., Zhang‐Negrerie, D., & Gao, Q. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.01.016 · Cited by 58
Lobiezz, P. E., Zhu, T., Graichen, R., & Goh, E. L. K. (2000) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(00)80010-6 · Cited by 55
Metformin prevents DMH ‐induced colorectal cancer in diabetic rats by reversing the warburg effect
Jia, Y., Ma, Z., Liu, X., Zhou, W., He, S., Xu, X., Ren, G., Xu, G., & Tian, K. (2015) · Cancer Medicine · doi:10.1002/cam4.521 · Cited by 54
Central IGF1 improves glucose tolerance and insulin sensitivity in mice
Hong, H., Cui, Z.-Z., Zhu, L., Fu, S.-P., Rossi, M., Cui, Y.-H., & Zhu, B.-M. (2017) · Nutrition & Diabetes · doi:10.1038/s41387-017-0002-0 · Cited by 54
Phytometabolites Targeting the Warburg Effect in Cancer Cells: A Mechanistic Review
Hasanpourghadi, M., Looi, C. Y., Pandurangan, A. K., Sethi, G., Wong, W. F., & Mustafa, M. R. (2016) · Current Drug Targets · doi:10.2174/1389450117666160401124842 · Cited by 52
A metabolic signature of colon cancer initiating cells
Chen, K.-Y., Liu, X., Bu, P., Lin, C.-S., Rakhilin, N., Locasale, J. W., & Shen, X. (2014) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2014.6944688 · Cited by 51
Energy Restriction and Colorectal Cancer: A Call for Additional Research
Castejón, M., Plaza, A., Martinez-Romero, J., Fernandez-Marcos, P. J., de Cabo, R., & Diaz-Ruiz, A. (2020) · Nutrients · doi:10.3390/nu12010114 · Cited by 51
Advances in glucose metabolism research in colorectal cancer
Fang, S., & Fang, X. (2016) · Biomedical Reports · doi:10.3892/br.2016.719 · Cited by 51
Zhang, X., Li, K., Feng, J., Liu, G., & Feng, Y. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.12.020 · Cited by 51
Physical inactivity, energy intake, obesity and the risk of rectal cancer in Canada
Mao, Y., Pan, S., Wen, S. W., & Johnson, K. C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11159 · Cited by 51
Ita, J. R. D., Castilla‐Cortázar, I., Aguirre, G. A., Sanchez-Yago, C., Santos-Ruiz, M. O., Guerra-Menéndez, L., Martín‐Estal, I., García‐Magariño, M., Díaz, V. J. L., Puche, J. E., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0684-9 · Cited by 50
Serum glucose and risk of cancer: a meta-analysis
Crawley, D., Holmberg, L., Melvin, J. C., Loda, M. F., Chowdhury, S., Rudman, S. M., & Hemelrijck, M. V. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-985 · Cited by 48
Sax, A. T., Jenkins, D. G., Devin, J. L., Hughes, G. I., Bolam, K. A., & Skinner, T. L. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.05.011 · Cited by 48
miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1
Santasusagna, S., Moreno, I., Navarro, A., Muñoz, C., Martinez, F., Hernández, R., Castellano, J. J., & Monzó, M. (2018) · Clinical & Translational Oncology · doi:10.1007/s12094-018-1836-1 · Cited by 48
Role of glucose metabolism related gene GLUT1 in the occurrence and prognosis of colorectal cancer
Feng, W., Cui, G., Tang, C., Zhang, X., Dai, C., Xu, Y., Gong, H., Xue, T., Guo, H., & Bao, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.18090 · Cited by 47
Álvarez‐Nava, F., & Lanes, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18101624 · Cited by 46
Survival of Colorectal Cancer Patients With Diabetes Mellitus: A Meta-Analysis
Petrelli, F., Ghidini, M., Rausa, E., Ghidini, A., Cabiddu, M., Borgonovo, K., Ghilardi, M., Parati, M. C., Pietrantonio, F., Sganzerla, P., et al. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.06.009 · Cited by 46
Pang, Y., Kartsonaki, C., Yu, C., Chen, Y., Yang, L., Bian, Z., Bragg, F., Millwood, I. Y., Shen, L., Zhou, S., et al. (2018) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2018-210651 · Cited by 46
Böni-Schnetzler, M., Hauri, C., & Zapf, J. (1999) · Diabetologia · doi:10.1007/s001250051134 · Cited by 45 · cited 1×
“that GH itself is likely to have a direct effect on lipid metabolism in IGF-1-independent mechanisms [99].”
BackgroundNiculescu, D., Purice, M., & Coculescu, M. (2012) · Pituitary · doi:10.1007/s11102-012-0396-6 · Cited by 45
Kabat, G. C., Kim, M. Y., Strickler, H. D., Shikany, J. M., Lane, D. S., Luo, J., Ning, Y., Gunter, M. J., & Rohan, T. E. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.512 · Cited by 45
Weigent, D. A., Baxter, J. B., & Blalock, J. E. (1992) · Brain Behavior and Immunity · doi:10.1016/0889-1591(92)90035-m · Cited by 45
Insights into the beneficial effect of caloric/ dietary restriction for a healthy and prolonged life
Pallavi, R., Giorgio, M., & Pelicci, P. G. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00318 · Cited by 45
MacDonald, R. S., Thornton, W. H., & Bean, T. L. (1993) · Journal of Receptor Research · doi:10.3109/10799899309063266 · Cited by 44
Cited by
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
Metabolic reprogramming consequences of sepsis: adaptations and contradictions
Liu, J., Zhou, G., Wang, X., & Liu, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04490-0 · Cited by 179
Dai, F., Zhang, J., Chen, F., Chen, X., Lee, C. J., Liang, H., Zhao, L., & Tan, H. F. (2024) · Advanced Science · doi:10.1002/advs.202408783 · Cited by 164
Targeting of the tumor immune microenvironment by metformin
Wu, Z., Zhang, C., & Najafi, M. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00648-w · Cited by 83
Screening for Coronary Artery Disease in Cancer Survivors
Velusamy, R., Nolan, M. T., Murphy, A. J., Thavendiranathan, P., & Marwick, T. H. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2022.12.007 · Cited by 90
Metadata
- Authors
- Kasprzak, A.
- Affiliations
- Poznan University of Medical Sciences (PL)
- Corresponding author
- Kasprzak, Aldona
- ORCID
- Kasprzak, Aldona
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-16
- Volume
- 22
- Issue
- 12
- Pages
- 6434
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8234711
- OpenAlex
- W3169775278
- Cited by
- 248
- References
- 284
- Citations by year
- 2026: 51 · 2025: 73 · 2024: 60 · 2023: 32 · 2022: 22 · 2021: 10
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- insulin-like growth factor I, colorectal cancer, glucose metabolism, Warburg effect, aerobic glycolysis, metabolic syndrome, hyperglycemia, PI3K/AKT/mTOR pathway, glucose transporters, GLUT1, glycolytic enzymes, c-Myc, KRAS, HIF-1, TGF-β1, colorectal carcinogenesis
- MeSH terms
- Animals, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Disease Susceptibility, Glucose, Humans, Insulin-Like Growth Factor I, Metabolic Diseases, Risk Factors, Colorectal Neoplasms, Signal Transduction, Biomarkers, Gene Expression Regulation, Neoplastic, Carbohydrate Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.